Kodiack can`t take a trick. First the failure of Wet AMD 2b trial and now problems with their DME trial.
Increasing the opportunity from a successful phase 3 for OPT 302
https://www.fiercebiotech.com/biotech/unexpected-cataracts-phase-3-trials-end-kodiaks-hopes-eye-drug-halving-stock-price
Increasing the opportunity
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.5¢ |
Change
-0.015(2.31%) |
Mkt cap ! $420.8M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 64.5¢ | 63.5¢ | $19.91K | 31.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 10837 | 63.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 11106 | 8 |
View Market Depth
| Last trade - 10.56am 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
64.0¢ |
Change
-0.015 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| 63.5¢ | 64.3¢ | 63.5¢ | 3616 | ||
| Last updated 11.18am 08/05/2024 ? | |||||
| OPT (ASX) Chart |